Immunizations in the United States: A rite of passage

Pediatric Clinics of North America

Volumn 52, Issue 3, 2005, Pages 669-693

  Cohn, Amanda C ^a   Broder, Karen R ^a   Pickering, Larry K ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

BEHAVIOR DISORDER; CHICKENPOX; CHILDHOOD DISEASE; COMMON COLD; CONGENITAL RUBELLA SYNDROME; DIPHTHERIA; ERADICATION THERAPY; HEALTH CARE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFLUENZA; INOCULATION; MEASLES; MENINGOCOCCOSIS; MUMPS; PERTUSSIS; POLIOMYELITIS; PUBLIC HEALTH; PUBLISHING; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; TETANUS; UNITED STATES; VIRUS INFECTION; WILD TYPE;

ADOLESCENT; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG APPROVAL; FINANCING, GOVERNMENT; FORECASTING; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; INFORMATION SERVICES; INSTITUTE OF MEDICINE (U.S.); MORBIDITY; PEDIATRICS; PRACTICE GUIDELINES; PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION;

EID: 19544376155     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.03.001     Document Type: Review

References (81)

1. F. Fenner, D.A. Henderson, and I. Arita Smallpox and its eradication 1998 WHO Geneva Available at: http://www.who.int/emc/diseases/smallpox/ Smallpoxeradication.html Accessed February 2005
2. Centers for Disease Control and Prevention Ten great public health achievements, United States MMWR Morb Mortal Wkly Rep 48 1999 241 243
3. Centers for Disease Control and Prevention Impact of vaccines universally recommended for children-United States, 1990-1998 MMWR Morb Mortal Wkly Rep 48 1999 243 248
4. W.A. Orenstein, M.J. Papania, and M.E. Wharton Measles elimination in the United States J Infect Dis 189 Suppl 1 2004 S1 S3
5. P.M. Strebel, R.W. Sutter, and S.L. Cochi Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease Clin Infect Dis 14 1992 568 579
6. US Department of Health and Human Services Healthy people 2010: national health promotion and disease prevention objectives 2000 US Public Health Service Washington (DC)
7. K.M. Bisgard, A. Kao, J. Leake, P.M. Strebel, B.A. Perkins, and M. Wharton Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease Emerg Infect Dis 4 1998 229 237
8. Centers for Disease Control and Prevention Recommended childhood and adolescent immunization schedule-United States, 2005 MMWR Morb Mortal Wkly Rep 53 2005 Q1 Q4
9. Centers for Disease Control and Prevention Recommended childhood immunization schedule-United States, January 1995. Advisory Committee on Immunization Practices, American Academy of Pediatrics, American Academy of Family Physicians, National Immunization Program, CDC MMWR Morb Mortal Wkly Rep 43 1995 959 960
10. L.K. Pickering, and W.A. Orenstein Development of pediatric vaccine recommendations and policies Semin Pediatr Infect Dis 13 2002 148 154
11. B. Schwartz, and W.A. Orenstein Vaccination policies and programs: the federal government's role in making the system work Prim Care 28 2001 697 711
12. A.R. Hinman, W.A. Orenstein, and L. Rodewald Financing immunizations in the United States Clin Infect Dis 38 2004 1440 1446
13. T.A. Lieu, S.L. Cochi, and S.B. Black Cost-effectiveness of a routine varicella vaccination program for US children JAMA 271 1994 375 381
14. T.A. Lieu, G.T. Ray, and S.B. Black Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children JAMA 283 2000 1460 1468
15. A.B. Coffield, M.V. Maciosek, and J.M. McGinnis Priorities among recommended clinical preventive services Am J Prev Med 21 2001 1 9
16. J. Sharfstein, and P. Wise Cost-effectiveness of hepatitis B virus immunization JAMA 275 1996 908
17. National Vaccine Advisory Committee Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee JAMA 290 2003 3122 3128
18. Centers for Disease Control and Prevention Shortage of tetanus and diphtheria toxoids MMWR Morb Mortal Wkly Rep 49 2000 1029 1030
19. Centers for Disease Control and Prevention Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine MMWR Morb Mortal Wkly Rep 50 2001 189 190
20. Centers for Disease Control and Prevention Notice to readers: decreased availability of pneumococcal conjugate vaccine MMWR Morb Mortal Wkly Rep 50 2001 783 784
21. Centers for Disease Control and Prevention Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 51 2002 190 197
22. Centers for Disease Control and Prevention Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage-United States, October-November, 2004 MMWR Morb Mortal Wkly Rep 53 2004 1153 1155
23. Centers for Disease Control and Prevention Notice to readers: pneumococcal conjugate vaccine shortage resolved MMWR Morb Mortal Wkly Rep 52 2003 446 447
24. S. Stokley, J.M. Santoli, B. Willis, V. Kelley, A. Vargas-Rosales, and L.E. Rodewald Impact of vaccine shortages on immunization programs and providers Am J Prev Med 26 2004 15 21
25. G.L. Freed, M.M. Davis, and S.J. Clark Variation in public and private supply of pneumococcal conjugate vaccine during a shortage JAMA 289 5 2003 575 578
26. Centers for Disease Control and Prevention Limited supply of pneumococcal conjugate vaccine: suspension of recommendation for fourth dose MMWR Morb Mortal Wkly Rep 53 2004 108 109
27. United States General Accounting Office Report to congressional requesters: childhood vaccines: ensuring an adequate supply poses continuing challenges. 2002 Available at: http://www.gao.gov/new.items/d02987.pdf Accessed Janurary 2005
28. R.T. Chen, R. Davis, and K.M. Sheedy Safety of immunizations: vaccine S.A. Plotkin W.A. Orenstein Vaccines 2004 WB Saunders Philadelphia 1557 1577
29. Centers for Disease Control and Prevention Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 49 RR-5 2000 1 22
30. Institute of Medicine Immunization safety review: committee reports 2004 National Academy of Sciences Washington, DC Available at: www.iom.edu/project. asp?id=4705 Accessed February 2005
31. F. Varricchio, J. Iskander, and F. Destefano Understanding vaccine safety information from the Vaccine Adverse Event Reporting System Pediatr Infect Dis J 23 2004 287 294
32. Centers for Disease Control and Prevention Withdrawal of rotavirus vaccine recommendation MMWR Morb Mortal Wkly Rep 48 1999 1007
33. Centers for Disease Control and Prevention Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 48 RR-2 1999 1 23
34. R.T. Chen, R.L. Davis, and K.M. Sheedy Safety of immunizations S.A. Plotkin W.A. Orenstein Vaccines 2004 WB Saunders Philadelphia 1557 1582
35. Centers for Disease Control and Prevention Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association MMWR Morb Mortal Wkly Rep 45 1996 1 16
36. Centers for Disease Control and Prevention Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 49 No. RR-9 2000 1 38
37. S. Black, H. Shinefield, and R. Baxter Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente Pediatr Infect Dis J 23 2004 485 489
38. S.L. Kaplan, E.O. Mason Jr, and E.R. Wald Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine Pediatrics 113 2004 443 449
39. C.G. Whitney, M.M. Farley, and J. Hadler Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 2003 1737 1746
40. K.A. Poehling, B.J. Lafleur, and P.G. Szilagyi Population-based impact of pneumococcal conjugate vaccine in young children Pediatrics 114 2004 755 761
41. B. Fireman, S.B. Black, H.R. Shinefield, J. Lee, E. Lewis, and P. Ray Impact of the pneumococcal conjugate vaccine on otitis media Pediatr Infect Dis J 22 2003 10 16
42. K.C. Lee, J.A. Finkelstein, and I.L. Miroshnik Pediatricians' self-reported clinical practices and adherence to national immunization guidelines after the introduction of pneumococcal conjugate vaccine Arch Pediatr Adolesc Med 158 2004 695 701
43. K.L. O'Brien, and M. Santosham Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases Am J Epidemiol 159 2004 634 644
44. G.L. Armstrong, E.E. Mast, M. Wojczynski, and H.S. Margolis Childhood hepatitis B virus infections in the United States before hepatitis B immunization Pediatrics 108 2001 1123 1128
45. G.A. Poland, and R.M. Jacobson Clinical practice: prevention of hepatitis B with the hepatitis B vaccine N Engl J Med 351 2004 2832 2838
46. Centers for Disease Control and Prevention Hepatitis B vaccination-United States, 1982-2002 MMWR Morb Mortal Wkly Rep 51 2002 549 552
47. Centers for Disease Control and Prevention Acute hepatitis B among children and adolescents-United States, 1990-2002 MMWR Morb Mortal Wkly Rep 53 2004 1015 1018
48. P.L. Raghunathan, S.A. Bernhard, and N.E. Rosenstein Opportunities for control of meningococcal disease in the US Annu Rev Med 55 2004 333 353
49. Centers for Disease Control and Prevention Prevention and control of meningococcal disease and meningococcal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 49 RR-7 2000 1 20
50. Centers for Disease Control and Prevention Active Bacterial Core Surveillance Report, Emerging Infections Program Network Available at: http://www.cdc.gov/ncidod/dbmd/abcs/reports.htm#pubs Accessed February 2005
51. Centers for Disease Control and Prevention Pertussis United States, 1997-2000 MMWR Morb Mortal Wkly Rep 51 2002 73 76
52. D. Guris, P.M. Strebel, and B. Bardenheier Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996 Clin Infect Dis 28 1999 1230 1237
53. Centers for Disease Control and Prevention Final: 2003 reports of notifiable diseases MMWR Morb Mortal Wkly Rep 53 2004 687 696
54. M. Tanaka, C.R. Vitek, F.B. Pascual, K.M. Bisgard, J.E. Tate, and T.V. Murphy Trends in pertussis among infants in the United States, 1980-1999 JAMA 290 2003 2968 2975
55. G.M. Lee, S. Lett, and S. Schauer Societal costs and morbidity of pertussis in adolescents and adults Clin Infect Dis 39 2004 1572 1580
56. G. De Serres, R. Shadmani, and B. Duval Morbidity of pertussis in adolescents and adults J Infect Dis 182 2000 174 179
57. K.W. Purdy, J.W. Hay, M.F. Botteman, and J.I. Ward Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis Clin Infect Dis 39 2004 20 28
58. K.M. Bisgard, F.B. Pascual, and K.R. Ehresmann Infant pertussis: who was the source? Pediatr Infect Dis J 23 2004 985 989
59. K.D. Forsyth, M. Campins-Marti, and J. Caro New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative Clin Infect Dis 39 2004 1802 1809
60. P. Scuffham, and P. McIntyre Pertussis vaccination strategies for neonates-an exploratory cost-effectiveness analysis Vaccine 22 2004 2953 2964
61. E.M. Burd Human papillomavirus and cervical cancer Clin Microbiol Rev 16 2003 1 17
62. C.D. Harro, Y.Y. Pang, and R.B. Roden Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine J Natl Cancer Inst 93 2001 284 292
63. L.A. Koutsky, K.A. Ault, and C.M. Wheeler A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645 1651
64. D.M. Harper, E.L. Franco, and C. Wheeler Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 2004 1757 1765
65. L.R. Zanardi, P. Haber, G.T. Mootrey, M.T. Niu, and M. Wharton Intussusception among recipients of rotavirus vaccine: reports to the Vaccine Adverse Event Reporting System Pediatrics 107 2001 E97
66. T.V. Murphy, P.M. Gargiullo, and M.S. Massoudi Intussusception among infants given an oral rotavirus vaccine N Engl J Med 344 2001 564 572
67. M. Iwamoto, T.N. Saari, and S.R. McMahon A survey of pediatricians on the reintroduction of a rotavirus vaccine Pediatrics 112 1 Pt 1 2003 e6 e10 Available at: www.pediatrics.aappublications.org/cgi/reprint/112/1/e6?maxtoshow= &HITS=10&hits=10&RESULTFORMAT=&author1=Iwamoto&searchid= 1107975380001_13871&stored_search=&FIRSTINDEX=0&sortspec= relevance&journalcode=pediatrics Accessed February 2005
68. J.F. Seward, B.M. Watson, and C.L. Peterson Varicella disease after introduction of varicella vaccine in the United States, 1995-2000 JAMA 287 2002 606 611
69. J.F. Seward, J.X. Zhang, T.J. Maupin, L. Mascola, and A.O. Jumaan Contagiousness of varicella in vaccinated cases: a household contact study JAMA 292 2004 704 708
70. S.L. Thomas, J.G. Wheeler, and A.J. Hall Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study Lancet 360 2002 678 682
71. W.W. Thompson, D.K. Shay, and E. Weintraub Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340
72. D. Kobasa, A. Takada, and K. Shinya Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus Nature 431 2004 703 707
73. C. Quach, L. Piche-Walker, and R. Platt Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy Pediatrics 112 2003 197 201
74. K.M. Neuzil, Y. Zhu, and M.R. Griffin Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective prospective study J Infect Dis 185 2002 147 152
75. H.S. Izurieta, W.W. Thompson, and P. Kramarz Influenza and the rates of hospitalization for respiratory disease among infants and young children N Engl J Med 342 2000 232 239
76. Centers for Disease Control and Prevention Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 53 No. RR-6 2004
77. Centers for Disease Control and Prevention Update: influenza-associated deaths reported among children aged < 18 years-United States, 2003-04 influenza season MMWR Morb Mortal Wkly Rep 52 2004 1286 1288
78. Liu M.A., Ulmer J.B., O'Hagan D. Vaccine technologies. In: US Department of Health and Human Services, editor. The Jordan Report, 20th Anniversary Accelerated Development of Vaccines (2002). Bethesda (MD): The Institute; 2002. p. 32-7
79. Vogel F.R., Alving C.R. Progress in immunologic adjuvant development: 1982-2002. In: US Department of Health and Human Services, editor. The Jordan Report, 20th Anniversary Accelerated Development of Vaccines (2002). Bethesda (MD): The Institute; 2002. p. 39-43
80. Institute of Medicine Financing vaccines in the 21st century: assuring access and availability 2003 National Academy of Sciences Washington, DC Available at: www.iom.edu/vaccinepriorities Accessed February 2005
81. K.S. Li, Y. Guan, J. Wang, and G.J. Smith Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia Nature 430 2004 209 213